Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".
Summary
H.J.Res. 187 is an early-stage congressional disapproval resolution targeting a CMS prior authorization rule (WISeR). It has been referred to two committees with only three cosponsors. The bill has no funding and is procedural; market impact is negligible.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.H.J.Res. 187 is a procedural disapproval resolution with no funding attached.
- 2.Only three cosponsors and referral to two committees indicate low momentum.
- 3.Market impact is negligible; no material change to Medicare Advantage operations.
Market Implications
The resolution has no near-term market impact. Medicare Advantage insurers like face no immediate regulatory change. The WISeR rule was not implemented, so nullification changes nothing. Investors should focus on other legislative drivers.
Full Analysis
- What happened: On May 19, 2026, Rep. Landsman (D-OH) introduced H.J.Res. 187 to disapprove a CMS rule implementing prior authorization for select services under the WISeR model. The resolution was referred to the Ways and Means and Energy and Commerce Committees. It is in early stage with only three cosponsors. 2) Money trail: This is a Congressional Review Act resolution — it does not authorize or appropriate any funds. It simply nullifies an existing rule. No spending is involved. 3) Winners and losers: The nullification would benefit Medicare Advantage insurers (, $HUM, $CI) by avoiding new prior authorization requirements. However, the rule was not yet in effect, so the impact is prospective and small. 4) Legislative timeline: The resolution must pass both chambers and be signed by the President to take effect. Given the divided Congress and early stage, passage is unlikely. 5) Market implications: Minimal. The WISeR model was not a major market-moving regulation. The resolution's failure to advance would leave the status quo unchanged.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations".
Expressing support for continued efforts to safeguard Medicare, Medicaid, and other Federal health care programs from fraud, waste, abuse, and improper payments through strengthened program integrity measures, enhanced oversight, and coordinated enforcement actions, and recognizing the work of the Trump administration and congressional Republicans to investigate and prosecute fraud and protect taxpayer dollars and preserve the long-term sustainability of the Nation's health care safety net.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.